BRIA-OTS

· BriaCell Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRIA-OTS, covering 2024-08-26 to 2024-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer [Phase 1, Phase 2]